Bijan Nejadnik - SanBio Company Chief Officer

SNBIF Stock  USD 3.85  0.00  0.00%   

Insider

Bijan Nejadnik is Chief Officer of SanBio Company Limited
Age 61
Phone81 3 6264 3481
Webhttps://www.sanbio.jp

SanBio Company Management Efficiency

The company has return on total asset (ROA) of (0.7379) % which means that it has lost $0.7379 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.1932) %, meaning that it generated substantial loss on money invested by shareholders. SanBio Company's management efficiency ratios could be used to measure how well SanBio Company manages its routine affairs as well as how well it operates its assets and liabilities.
SanBio Company Limited has accumulated 2.01 B in total debt with debt to equity ratio (D/E) of 0.59, which is about average as compared to similar companies. SanBio Limited has a current ratio of 5.34, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist SanBio Company until it has trouble settling it off, either with new capital or with free cash flow. So, SanBio Company's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like SanBio Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for SanBio to invest in growth at high rates of return. When we think about SanBio Company's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 5 records

INSIDER Age

Guizhong LiuAdagene
53
Fangyong DuAdagene
54
Qinghai ZhaoAdagene
63
Man MBAAdagene
47
Jc MDAdagene
59
SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company was founded in 2001 and is headquartered in Tokyo, Japan. Sanbio is traded on OTC Exchange in the United States. SanBio Company Limited [SNBIF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

SanBio Limited Leadership Team

Elected by the shareholders, the SanBio Company's board of directors comprises two types of representatives: SanBio Company inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SanBio. The board's role is to monitor SanBio Company's management team and ensure that shareholders' interests are well served. SanBio Company's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SanBio Company's outside directors are responsible for providing unbiased perspectives on the board's policies.
Keita MBA, President, Executive Officer and Representative Director
Greg Gillas, Sr Services
Toru Kawanishi, Chairman and Executive Officer
Michael McGrogan, VP Devel
Kazumi Sawaguchi, Co Japan
Andrew Liu, Co Officer
Yoshihiro Kakutani, Co Admin
Akihiro MBA, COO VP
Naoki Tsukahara, Corp Head
Bijan Nejadnik, Chief Officer

SanBio Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is SanBio Company a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in SanBio OTC Stock

SanBio Company financial ratios help investors to determine whether SanBio OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SanBio with respect to the benefits of owning SanBio Company security.